| | | | | |
AGIO Agios Pharmaceuticals, Inc. | $29.0400 | +4.91% | $1.74B | $245.66K | |
SGRY Surgery Partners, Inc. Common Stock | $13.5350 | +0.19% | $1.74B | $659.92K | |
GAB The Gabelli Equity Trust Inc. | $5.5850 | -0.45% | $1.74B | $1.06M | |
HURN Huron Consulting Group Inc. | $106.93 | +2.02% | $1.74B | $53.73K | |
ENVX Enovix Corporation Common Stock | $8.4330 | +2.47% | $1.74B | $4.17M | |
PAYO Payoneer Global Inc. Common Stock | $5.1250 | +0.69% | $1.74B | $1.92M | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | $14.9400 | +0.20% | $1.73B | $142.64K | |
STGW Stagwell Inc. Class A Common Stock | $6.6250 | +0.53% | $1.73B | $504.80K | |
CASH Pathward Financial, Inc. Common Stock | $78.9000 | +1.49% | $1.73B | $101.70K | |
SNDX Syndax Pharmaceuticals, Inc. | $17.8250 | -2.81% | $1.73B | $5.22M | |
STRA Strategic Education, Inc. Common Stock | $80.5550 | +1.90% | $1.73B | $111.12K | |
CAPR Capricor Therapeutics Inc | $28.1900 | +1.99% | $1.73B | $290.33K | |
AAPG Ascentage Pharma Group International American Depository Shares | $18.4200 | +3.08% | $1.73B | $1.77K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | $9.1450 | +11.66% | $1.73B | $5.82M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | $27.1350 | +8.58% | $1.73B | $340.12K | |
